These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 3773263)

  • 1. [Biliary excretion and clinical evaluation of cefoperazone in the biliary tract infections].
    Koizumi M; Simosegawa T; Yanbe M; Goto Y; Sugawara H; Kanno Y; Kanazawa Y; Kai Y; Sato T; Endou K
    Jpn J Antibiot; 1986 Jul; 39(7):1663-70. PubMed ID: 3773263
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Clinical investigation of the biliary excretion of cefoperazone in obstructive jaundice].
    Matsumoto T; Moriwaki M; Iizuka Y
    Jpn J Antibiot; 1986 Oct; 39(10):2795-802. PubMed ID: 3806961
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Studies on cefoperazone concentration in human biliary tract and clinical effect for acute cholecystitis and cholangitis (author's transl)].
    Hirasawa S; Abe H; Bekki E; Hashimoto I; Sawada Y; Nakamura T; Mikami J; Watanabe Y
    Jpn J Antibiot; 1980 Dec; 33(12):1294-300. PubMed ID: 6454012
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical studies with cefoperazone in the biliary disease].
    Morinaga T; Furukawa M; Nakata T; Yamada R; Itoh S; Maeda S; Itose K; Ohtsubo M
    Jpn J Antibiot; 1985 Jan; 38(1):128-32. PubMed ID: 3989972
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [A pharmacokinetic study of cefoperazone during percutaneous transhepatic cholangial catheterization].
    Suwa T; Toyama N; Hirakata S; Suzuki F; Oki A; Sato T; Miyoshi K; Sakimura K; Kurane R; Sakai H
    Jpn J Antibiot; 1985 Aug; 38(8):2033-44. PubMed ID: 4078998
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Studies on sulbactam/cefoperazone in the field of pediatrics].
    Iwai N; Taneda Y; Shibata M; Mizoguchi F; Katayama M
    Jpn J Antibiot; 1984 Oct; 37(10):1859-79. PubMed ID: 6094865
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Fundamental and clinical studies of sulbactam/cefoperazone in the pediatric field].
    Iwata S; Sato Y; Iwasaki Y; Hayano S; Wakabayashi R; Kojima Y; Akita H; Sunakawa K; Oikawa T; Osano M
    Jpn J Antibiot; 1984 Oct; 37(10):1831-45. PubMed ID: 6094863
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Laboratory and clinical investigations of cefotiam in surgical biliary tract infections].
    Oikawa M; Watanabe I
    Jpn J Antibiot; 1982 May; 35(5):1153-62. PubMed ID: 6290699
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Chemotherapy on the biliary tract infections. XIII. Miloxacin, a novel chemotherapeutic agent, its excretion into bile and clinical effect on the biliary tract infections (author's transl)].
    Jpn J Antibiot; 1981 Sep; 34(9):1335-52. PubMed ID: 7328756
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Bacteriological, pharmacokinetic and clinical studies on sulbactam/cefoperazone in the pediatric field].
    Fujii R; Meguro H; Arimasu O; Mashiko J; Tajima T; Nonaka C; Nagamatsu I; Sato Y; Honjo T; Watanabe A
    Jpn J Antibiot; 1984 Dec; 37(12):2427-56. PubMed ID: 6098739
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical studies of cefoperazone in neurosurgery].
    Kitamura K; Shimizu T; Abe H; Suzuki J; Tanaka R; Nagai H; Yamamoto S; Handa H; Nishimoto A; Matsuoka K
    Jpn J Antibiot; 1986 Jan; 39(1):63-74. PubMed ID: 2939268
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical evaluation of sulbactam/cefoperazone in lower respiratory tract infections].
    Ishibashi T; Takamoto M; Shinoda A; Yoshida M; Ichikawa Y; Kido M; Ninomiya K; Kitahara Y; Hara N; Tsurutani H
    Jpn J Antibiot; 1990 Feb; 43(2):239-56. PubMed ID: 2194054
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Fundamental and clinical studies on sulbactam/cefoperazone in the field of obstetrics and gynecology].
    Cho N; Watanabe H; Yoshida K; Moriyama S; Takeda H; Tsukamoto A; Fukunaga K; Kunii K
    Jpn J Antibiot; 1984 Oct; 37(10):1939-55. PubMed ID: 6094873
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Studies on tissue concentrations of cefoperazone and piperacillin classified by the site of the wall of gallbladder and concentration of piperacillin in the bile after operation].
    Shima K; Ueno K; Ooto T; Shima Y; Miyata T; Sei T; Yonemura Y; Uemura T; Takano N
    Jpn J Antibiot; 1984 Jun; 37(6):966-72. PubMed ID: 6492387
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Basic and clinical evaluation of sulbactam/cefoperazone in the field of pediatrics].
    Toyonaga Y; Kurosu Y; Nakamura H; Sugita M; Takahashi T; Hori M
    Jpn J Antibiot; 1984 Dec; 37(12):2457-77. PubMed ID: 6098740
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Study of cefoperazone in the field of obstetrics and gynecology. Susceptibility of clinical isolates to cefoperazone and cefoperazone concentrations in the exudate of the pelvic dead space].
    Cho N; Kimura T; Suzuki H; Fukunaga K; Kunii K; Komoriyama Y
    Jpn J Antibiot; 1984 Sep; 37(9):1607-19. PubMed ID: 6512980
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Laboratory and clinical study of sulbactam/cefoperazone (SBT/CPZ) on bacterial prostatitis].
    Suzuki K; Horiba M
    Hinyokika Kiyo; 1991 Oct; 37(10):1333-43. PubMed ID: 1755429
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical studies on cefoperazone treatment for bile duct infections (author's transl)].
    Hirayama T; Kikuchi K
    Jpn J Antibiot; 1981 Jun; 34(6):934-8. PubMed ID: 6457179
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Excretion of antibiotics into bile and urine in patients with external cholecystostomy done in order to treat obstructive jaundice].
    Hidaka K; Yamamoto H; Harada S; Katano M; Fujiwara H; Mizoguchi T; Hisatsugu T; Yamaoka K; Kisu T
    Jpn J Antibiot; 1988 Sep; 41(9):1295-303. PubMed ID: 3241327
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Fundamental and clinical studies of sulbactam/cefoperazone in the pediatric field].
    Motohiro T; Tanaka K; Koga T; Shimada Y; Tomita N; Sakata Y; Fujimoto T; Nishiyama T; Ishimoto K; Tominaga K
    Jpn J Antibiot; 1984 Oct; 37(10):1898-918. PubMed ID: 6094868
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.